trending Market Intelligence /marketintelligence/en/news-insights/trending/fs43lb6au7udyj9f_kqleq2 content esgSubNav
In This List

VentriPoint Diagnostics gets US FDA clearance for heart ultrasound machine

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


VentriPoint Diagnostics gets US FDA clearance for heart ultrasound machine

Canada's VentriPoint Diagnostics Ltd. said the U.S. Food and Drug Administration granted market clearance for its VMS+ echocardiography system.

The VMS+ was approved for the 3D volumetric analysis of all four chambers of the heart using 2D ultrasound.

VentriPoint develops and sells diagnostic tools that monitor patients with heart disease.